Health consequences of marijuana use

Handbook of the Medical Consequences of Alcohol and Drug Abuse, Second Edition

Volumn , Issue , 2012, Pages 251-301

  Budney, Alan J ^a   Moore, Brent A ^b   Vandrey, Ryan ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960907594     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203836590-16     Document Type: Chapter

References (294)

1. Abel, E.L. (1971). Effects of marijuana on the solution of anagrams, memory, and appetite. Nature, 231:260-261.
2. Aceto, M.; Scates, S.; Lowe, J.; Martin, B. (1996). Dependence on delta-9 tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther, 278:1290-1295.
3. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.
4. Andreasson, S.; Allebeck, P.; Engstrom, A.; Rydberg, U. (1987). Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 2:1483-1486.
5. Andreasson, S.; Allebeck, P.; Rydberg, U. (1989). Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand, 79:505-510.
6. Anthony, J.C.; Helzer, J.E. (1991). Syndromes of drug abuse and dependence. In: Robins, L.N.; Regier, D.A. (eds.), Psychiatric Disorders in America (pp. 116-154). New York: Free Press.
7. Anthony, J.; Warner, L.; Kessler, R. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings fromthe National Comorbidity Survey. Exp Clin Psychopharmacol, 2:244-268.
8. Azorlosa, J.L.; Heishman, S.J.; Stitzer, M.L.; Mahaffey, J.M. (1992). Marijuana smoking: Effect of varying delta-9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp Ther, 261:114-122.
9. Baldwin, G.C.; Tashkin, D.P.; Buckley, D.M.; Park, A.N.; Dubinett, S.M.; Roth, M.D. (1997). Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am JRespir Crit Care Med, 156:1606-1613.
10. Barbers, R.G.; Evans, M.J.; Gong, H.; Tashkin, D.P. (1991). Enhanced alveolar monocytic phagocyte (macrophage) proliferation in tobacco and marijuana smokers. Am Rev Respir Dis, 143:1092-1095.
11. Barsky, S.F.; Roth, M.D.; Kleerup, E.C.; Simmons, M.; Tashkin, D.P. (1998). Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Nad Cancer Inst, 90:1198-1205.
12. Bartels, S.J.; Teague, G.B.; Drake, R.E.; Clark, R.E.; Bush, P.W.; Noordsy, D.L. (1993). Substance abuse in schizophrenia: Service utilization and costs. J Nerv Ment Dis, 181:227-232.
13. Bates, M.N.; Blakely, T.A. (1999). Role of cannabis in motor vehicle crashes. Epidemiol Rev, 21:222-232.
14. Beaconsfield, P.; Ginsburg, J.; Rainsbury, R. (1972). Marijuana smoking: Cardiovascular effects in man and possible mechanisms. N Engl J Med, 287:209-212.
15. Beal, J.F.; Olson, R.; Laubenstein, L.; Morales, J.O.; Bellman, P.; Yango, B.; Lefkowitz, L.; Plasse, T.F.; Shepard, K.V. (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage, 10:89-97.
16. Beal, J.F.; Olson, R.; Lefkowitz, L.; Laubenstein, L.; Bellman, P.; Yango, B.; Morales, J.O. et al. (1997). Long-term efficacy and safety of dronabinol for anorexia. J Pain Symptom Manage, 14:7-14.
17. Beardsley, P.M.; Balster, R.L.; Harris, L.S. (1986). Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther, 239:311-319.
18. Benowitz, N.L.; Jones, R.T. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther, 18:287-297.
19. Black, S.; Casswell, S. (1993). Drugs in New Zealand: A Survey in 1990. Auckland, New Zealand: University of Auckland, Alcohol and Public Health Research Unit.
20. Block, R.I.; Farinpour, R.; Braverman, K. (1992). Acute effects of marijuana on cognition: Relationships to chronic effects and smoking techniques. Pharmacol Biochem Behav, 43:907-917.
21. Block, R.I.; Farinpour, R.; Schelchtem, J.A. (1991). Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend, 28:121-128.
22. Block, R.I.; Wittenborn, J.R. (1984a). Marijuana effects on semantic memory: Verification of common and uncommon category members. Psychol Rep, 55:503-512.
23. Block, R.I.; Wittenborn, J.R. (1984b). Marijuana effects on visual imagery in a paired-associate task. Percept Mot Skills, 58:759-766.
24. Bloom, J.W.; Kaltenborn, W.T.; Paoletti, P.; Camilli, A.; Lebowitz, M.D. (1987). Respiratory effects of non-tobacco cigarettes. Br Med J, 295:1516-1518.
25. Bolla, K.I.; Brown, K.; Eldreth, D.; Tate, K.; Cadet, J.L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59:1337-1343.
26. Brooks, J.S.; Balka, E.B.; Whiteman, M. (1999). The risks for late adolescence of early adolescent marijuana use. Am J Public Health, 89(10):1549-1554.
27. Budney, A.J.; Higgins, S.T.; Radonovich, K.J.; Novy, P.L. (2000). Adding voucher based incentives to coping-skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol, 68:1051-1061.
28. Budney, A.J.; Hughes, J.R. (2006). The cannabis withdrawal syndrome. Curr Opin Psychiatry, 19:233-238.
29. Budney, A.J.; Hughes, J.R.; Moore, B.A.; Novy, P.L. (2001). Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry, 58:917-924.
30. Budney, A.J.; Hughes, J.R.; Moore, B.A.; Vandrey, R.A. (2004). A Review of the validity and significance of the cannabis withdrawal syndrome. Am J Psychiatry, 161:1967-1977.
31. Budney, A.J.; Kandel, D.; Cherek, D.R.; Martin, B.R.; Stephens, R.S.; Roffman, R. (1997). Marijuana use and dependence: College on problems of drug dependenceannualmeeting, Puerto Rico (June, 1996). Drug Alcohol Depend, 45:1-11.
32. Budney, A.J.; Moore, B.A. (2002). Development and consequences of cannabis dependence. J Clin Pharmacol, 42(11 Suppl):28S-33S.
33. Budney, A.J.; Moore, B.A.; Higgins, S.T.; Rocha, H.L. (2006). Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consul Clin Psychol, 74:307-316.
34. Budney, A.J.; Moore, B.A.; Vandrey, R.; Hughes, J.R. (2003). The time course and significance of cannabis withdrawal. J Abnorm Psychol, 112(3): 393-402.
35. Budney, A.J.; Novy, P.; Hughes, J.R. (1999). Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction, 94(9):1311-1322.
36. Budney, A.J.; Radonovich, K.J.; Higgins, S.T.; Wong, C.J. (1998). Adults seeking treatment for marijuana dependence: A comparison to cocaine-dependent treatment seekers. Exp Clin Psychopharmacol, 6:419-426.
37. Burns, M.; Moskowitz, H. (1981). Alcohol, marijuana, and skills performance. In: Goldburg, L. (ed.), Alcohol, Drugs and Traffic Safety (pp. 954-968). Stockholm: Almqvist and Wiksell International.
38. Caiaffa, W.T.; Vlahov, D.; Graham, N.M.; Astemborski, J.; Solomon, L.; Nelson, K.E.; Munoz, A. (1994). Drug smoking, pneumocystis carinii pneumonia and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med, 150:1493-1498.
39. Caplan, G.A.; Brigham, B.A. (1990). Marijuana smoking and carcinoma of the tongue: Is there an association? Cancer, 66:1005-1006.
40. Cappell, H.D.; Pliner, P.L. (1973). Volitional control of marijuana intoxication: A study of the ability to come down on command. J Abnorm Psychol, 1:428-434.
41. Carter, W.E.; Coggins, W.; Doughty, P.L. (1977). Cannabisin Costa Rica: A Study of Chronic Marijuana Use. Philadelphia: Institute for the Study of Human Issues.
42. Casswell, S. (1977). Cannabis and alcohol: Effects on closed course driving behaviour. In: Johnson, I. (ed.), Seventh International Conference on Alcohol, Drugs, and Traffic Safety (pp. 238-246). Melbourne, Australia.
43. Casswell, S.; Marks, D.F. (1973). Cannabis and temporal disintegration in experienced and naive subjects. Science, 179:803-805.
44. Chait, L.D. (1990). Subjective and behavioral effects of marijuana the morning after smoking. Psychopharmacology (Berl), 100:328-333.
45. Chait, L.D.; Corwin, R.L.; Johanson, C.E. (1988). A cumulative dosing procedure for administering marijuana smoke to humans. Pharmacol Biochem Beh, 29: 553-557.
46. Channabasavanna, S.M.; Paes, M.; Hall, W. (1999). Mental and behavioral disorders due to cannabis. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 267-290). Toronto: Centre for Addictions and Mental Health.
47. Chasnoff, I.J. (1990). Cocaine use in pregnancy: Effect on infant neurobehavioural functioning. Paper presented at the American Society for Pharmacology and Experimental Therapeutics, Washington, DC.
48. Chen, C.Y.; Wagner, F.A.; Anthony, J.C. (2002). Marijuana use and the risk of major depressive episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol, 37:199-206.
49. Chesher, G.B.; Bird, K.D.; Jackson, D.M.; Perrignon, A.; Starmer, G.A. (1990). The effects of orally administered delta-9-tetrahydrocannabinol in man on mood and performance measures: A dose-response study. Pharmacol Biochem Behav, 35:861-864.
50. Clark, W.C.; Janal, M.N.; Zeidenberg, P.; Nahas, G.G. (1981). Effects of moderate and high doses of marihuana on thermal pain: A sensory decision theory analysis. J Clin Pharmacol, 21:S299-S310.
51. Clifford, D.B. (1983). Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol, 13:669-671.
52. Cohen, S. (1982). Cannabis effects upon adolescent motivation. Marijuana and Youth: Clinical Observations on Motivation and Learning (pp. 2-10). Rockville, MD: National Institute on Drug Abuse.
53. Compton, D.R.; Dewey, W.L.; Martin, B.R. (1990). Cannabis dependence and tolerance production. Adv Alcohol Subst Abuse, 9:129-147.
54. Cone, E.J.; Johnson, R.E.; Moore, J.D.; Roache, J.D. (1986). Acute effects of smoking marijuana on hormones subjective effects and performance in male human subjects. Pharmacol Biochem Behav, 24:1749-1754.
55. Consroe, P.; Musty, R.; Rein, J.; Tillery, W.; Pertwee, R. (1997). The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol, 38:44-48.
56. Consroe, P.; Sandyk, R.; Snider, S.R. (1986). Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci, 30:277-282.
57. Crowley, T.J.; MacDonald, M.J.; Whitmore, E.A.; Mikulich, S.K. (1998). Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct disorder symptoms and substance use disorders. Drug Alcohol Depend, 50:27-37.
58. Day, N.; Richardson, G.A. (1991). Prenatal marijuana use: Epidemiology, methodological issues and infant outcome. In: Chasnoff, I. (ed.), Clinics in Perinatology (pp. 77-92). Philadelphia: W.B. Saunders.
59. Day, N.; Richardson, G.A.; Goldschmidt, L.; Robles, N.; Taylor, P.M.; Stoffer, D.S.; Cornelius, M.D.; Geva, D. (1994). The effect of prenatal exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol, 16:169-176.
60. deFonseca, F.R.; Carrera, M.R.A.; Navarro, M.; Koob, G.F.; Weiss, F. (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 276:2050-2054.
61. Degenhardt, L.; Hall, W.; Lynskey, M. (2001). Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction, 96: 1603-1614.
62. Degenhardt, L.; Hall, W.; Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98:1493-1504.
63. Devane, W.A.; Dysarz, F.A.; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol, 34:605-613.
64. Deykin, E.Y.; Levy, J.C.; Wells, V. (1986). Adolescent depression, alcohol, and drug abuse. Am J Public Health, 76:178-182.
65. Diana, M.; Melis, M.; Muntoni, A.L.; Gessa, G.L. (1998). Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci USA, 95: 10269-10273.
66. Didcott, P.; Reilly, D.; Swift, W.; Hall, W. (1997). Long Term Cannabis Users on the New South Wales North Coast. Sydney: National Drug and Alcohol Research Centre.
67. Donald, PJ. (1991). Advanced malignancy in the young marijuana smoker. Adv Exp Med Biol, 288:33-46.
68. Dornbush, R.L.; Fink, M.; Freedman, A.M. (1971). Marijuana memory and perception. Am J Psychiatry, 128:194-197.
69. Dott, A.B. (1972). Effect of Marijuana on Risk Acceptance in a Simulated Passing Task. Washington, DC: U.S. Government Printing Office.
70. Dunn, M.; Davis, R. (1974). The perceived effects of marijuana on spinal cord injured males. Paraplegia, 12:175.
71. Ehrenreich, H.; Rinn, T.; Kunert, H.J.; Moeller, M.R.; Poser, W.; Schilling, L.; Gigerenzer, G.; Hoehe, M.R. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl), 142:295-301.
72. Ellickson, P.; Bui, K.; Bell, R.; McGuigan, K.A. (1998). Does early drug use increase the risk of dropping out of high school? J Drug Issues, 28:357-380.
73. Ellingstad, V.S.; McFarling, L.H.; Struckman, D.L. (1973). Alcohol, Marijuana, and Risk Taking. Vermillion, SD: South Dakota University, Vermillion Human Factors Laboratory.
74. Fergusson, D.M.; Horwood, L.J. (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92(3):279-296.
75. Fergusson, D.M.; Horwood, L.J.; Beautrais, A.L. (2003). Cannabis and educational achievement. Addiction, 98:1681-1692.
76. Fergusson, D.M.; Horwood, L.J.; Swain-Campbell, N. (2002). Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction, 97: 1123-1135.
77. Fergusson, D.M.; Lynskey, M.T.; Horwood, L.J. (1996). The short-term consequences of early cannabis use. J Abnorm Child Psychol, 24(4):499-512.
78. Fligiel, S.E.G.; Beals, T.F.; Tashkin, D.P.; Paule, M.G.; Scallet, A.L.; Ali, S.F.; Bailey, J.R.; Slikker, W. Jr. (1991). Marijuana exposure and pulmonary alterations in primates. PharmacolBiochem Behav, 40:637-642.
79. Fligiel, S.E.G.; Roth, M.D.; Kleerup, E.C.; Barsky, S.H.; Simmons, M.S.; Tashkin, D.P. (1997). Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest, 112:319-326.
80. Foltin, R.W.; Brady, J.V.; Fischman, M.W. (1986). Behavioral analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav, 25:577-582.
81. Foltin, R.W.; Fischman, M.W. (1988). Effects of smoked marijuana on human social behavior in small groups. Pharmacol Biochem Behav, 30:539-541.
82. Foltin, R.W.; Fischman, M.W.; Brady, J.V; Bernstein, D.J.; Capriotti, R.M.; Nellis, M.J.; Kelly, T.H. (1990). Motivational effects of smoked marijuana: Behavioral contingencies and low-probability activities. J Exp Anal Behav, 53(1):5-19.
83. Foltin, R.W.; Fischman, M.W.; Pippen, P.A.; Kelly, T.H. (1993). Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend, 32:93-106.
84. Fried, P.A. (1980). Marijuana use by pregnant women: Neurobehavioral effects in neonates. Drug Alcohol Depend, 6:415-424.
85. Fried, P.A.; Barnes, M.V.; Drake, E.R. (1985). Soft drug use after pregnancy compared to use before and during pregnancy. Am J Obstet Gynecol, 151:787-792.
86. Fried, P.A.; Watkinson, B. (1988). 12- and 24-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. Neurotoxicol Teratol, 10:305-313.
87. Fried, P.A.; Watkinson, B. (1990). 36- and 48-month neurobehavioural follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr, 11:49-58.
88. Fried, P.A.; Watkinson, B. (2000). Visuoperceptual functioning differs in 9- to 12 year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol, 22:11-20.
89. Fried, P.; Watkinson, B.; Gray, R. (2003). Differential effects on cognitive functioning in 13- to 16-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol, 25:427-436.
90. Fung, M.; Gallagher, C.; Machtay, M. (1999). Lung and aero-digestive cancers in young marijuana smokers. Tumori, 85:140-142.
91. Galanter, M.; Weingartner, H.; Vaughn, T.B.; Roth, W.T.; Wyatt, R.J. (1973). Delta-9-transtetrahydrocannabinol and natural marijuana. Arch Gen Psychiatry, 28: 278-281.
92. Georgotas, A.; Zeidenberg, P. (1979). Observations on the effects of four weeks of heavy marijuana smoking on group interaction and individual behavior. Compr Psychiatry, 20:427-432.
93. Gibson, G.T.; Baghurst, P.A.; Colley, D.P. (1983). Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust NZ J Obstet Gynaecol, 23:15-19.
94. Gil, E.; Chen, B.; Kleerup, E.; Webber, M.; Tashkin, D.P. (1995). Acute and chronic effects of marijuana smoking on pulmonary alveolar permeability. Life Sci, 56:2193-2199.
95. Goldschmidt, L.; Day, N.L.; Richardson, G.A. (2000). Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol, 22:325-336.
96. Gong, H.; Fligiel, S.; Tashkin, D.P.; Barbers, R.G. (1987). Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis, 136:142-149.
97. Gralla, R.J.; Tyson, L.B.; Bordin, L.A.; Clark, R.A.; Kelsen, D.P.; Kris, M.G.; Kalman, L.B.; Groshen, S. (1984). Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Cancer Treat Rep, 68:163-172.
98. Grant, I.; Gonzalez, R.; Carey, C.L.; Natarajan, L.; Wolfson T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. J Int Neuropsychol Soc, 9(5):679-689.
99. Green, B.E.; Ritter, C. (2000). Marijuana use and depression. J Health Soc Behav, 41:40-49.
100. Greenberg, H.S.; Werness, S.A.; Pugh, J.E.; Andrus, R.O.; Anderson, D.J.; Domino, E.F. (1994). Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharmacol Ther, 55:324-328.
101. Greenburg, I.; Kuehnle, J.; Mendelson, J.H.; Bernstein, J.G. (1976). Effects of marijuana use on body weight and caloric intake in humans. Psychopharmacology (Berl), 49:79-84.
102. Greenwald, M.K.; Stitzer, M.L. (2000). Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend, 59:261-275.
103. Grinspoon, L.; Bakalar, J.B. (1997). Marihuana, the Forbidden Medicine (p. 296). New Haven, CT: Yale University Press.
104. Grunberg, S.M.; Hesketh, PJ. (1993). Control of chemotherapy-induced emesis. N Engl J Med, 329:1790-1796.
105. Haas, A.P.; Hendin, H. (1987). The meaning of chronic marijuana use among adults: A psychosocial perspective. J Drug Issues, 17:333-348.
106. Halikas, J.A.; Weller, R.A.; Morse, C.L.; Hoffman, R.G. (1983). Regular marijuana use and its effects on psychosocial variables: Longitudinal study. Compr Psychiatry, 24:229-235.
107. Halikas, J.A.; Weller, R.A.; Morse, C.; Shapiro, T. (1982). Incidence and characteristics of amotivational syndrome, including associated findings, among chronic marijuana users. Marijuana and Youth: Clinical Observations on Motivation and Learning (pp. 11-26). Rockville, MD: National Institute on Drug Abuse.
108. Hall, W. (1999). Assessing the health and psychological effects of cannabis use. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R. G. (eds.), The Health Effects of Cannabis (pp. 1-18). Toronto: Centre for Addiction and Mental Health.
109. Hall, W.; Christie, M.; Currow, D. (2005). Cannabinoids and cancer: Causation, remediation, and palliation. Lancet Oncology, 6(1):35-42.
110. Hall, W.; Johnston, L.; Donnelly, N. (1999). Epidemiology of cannabis use and its consequences. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 69-126). Toronto: Centre for Addiction and Mental Health.
111. Hall, W.; Room, R.; Bondy, S. (1999). Comparing the health and psychological risks of alcohol, cannabis, nicotine, and opiate use. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 475-495). Toronto: Centre for Addiction and Mental Health.
112. Hall, W.; Solowij, N.; Lemon, J. (1994). The Health and Psychological Consequences ofCannabis Use. Canberra, Australia: Australian Government Publication Services.
113. Haney, M.; Comer, S.D.; Ward, A.S.; Foltin, R.W.; Fischman, M.W. (1999). Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl), 14:385-394.
114. Haney, M.; Gunderson, E.W.; Rabkin, J.; Hart, L.L.; Vosburg, S.; Comer, S.; Foltin, R.W. (in press). Dronabinol and marijuana in HIV-positive marijuana smokers: Caloric intake, mood, and sleep. J Acquired Immune Deficiency Syndrome.
115. Haney, M.; Ward, A.S.; Comer, S.D.; Foltin, R.W.; Fischman, M.W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl), 14:395-404.
116. Hansteen, R.W.; Miller, R.D.; Lonero, L. (1976). Effects of cannabis and alcohol on automobile driving and psychomotor tracking. Ann NY Acad Sci, 282:240-256.
117. Hatch, E.E.; Bracken, M.B. (1986). Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol, 124:986-993.
118. Heishman, S.J.; Arasteh, K.; Stitzer, M.L. (1997). Comparative effects of alcohol and marijuana on mood, memory and performance. Pharmacol Biochem Behav, 58:93-101.
119. Heishman, S.J.; Stitzer, M.L.; Bigelow, G.E. (1988). Alcohol and marijuana: Comparative dose effect profiles in humans. Pharmacol Biochem Behav, 31:649-655.
120. Heishman, S.J.; Stitzer, M.L.; Yingling, J.E. (1989). Effects of tetrahydrocannabinol content on marijuana smoking behavior: Subjective reports and performance. Pharmacol Biochem Behav, 34:173-179.
121. Hendin, H.; Haas, A.P.; Singer, P.; Eller, M.; Ulman, R. (1987). Living High: Daily Marijuana Use Among Adults. New York: Human Sciences Press.
122. Higgins, S.T.; Stitzer, M.L. (1986). Acute marijuana effects on social conversation. Psychopharmacology (Berl), 89:234-238.
123. Hill, S.Y.; Schwin, R.; Goodwin, D.W.; Powell, B.J. (1974). Marijuana and pain. J Pharmacol Exp Ther, 188:415-418.
124. Hingson, R.; Alpert, J.; Day, N.; Dooling, E.; Kayne, H.; Morelock, S.; Oppenheimer, E.; Zuckerman, B. (1982). Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics, 70:539-546.
125. Hoffman, D.; Brunnemann, K.D.; Gori, G.B.; Wynder, E.L. (1975). On the carcinogenicity of marijuana smoke. In: Runeckles, V.C. (ed.), Recent Advances in Phytochemistry (pp. 63-81). New York: Plenum Press.
126. Hollister, L.E. (1971). Hunger and appetite after single doses of marijuana, alcohol, and dextroamphetamine. Clin Pharmacol Ther, 12:44-49.
127. Hollister, L.E. (2000). An approach to the medical marijuana controversy. Drug Alcohol Depend, 58:3-7.
128. Hooker, W.D.; Jones, R.T. (1987). Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psycho-phamacologia, 91:20-24.
129. Huber, G.L.; First, M.W.; Grubner, O. (1991). Marijuana and tobacco smoke gasphase cytotoxins. Pharmacol Biochem Behav, 40:629-636.
130. Hutchings, D.E.; Fried, P.A. (1999). Cannabis during pregnancy: Neurobehavioral effects in animals and humans. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 401-434). Toronto: Centre for Addiction and Mental Health.
131. Institute of Medicine (1982). Marijuana and Health. Washington, DC: National Academy Press, Institute of Medicine.
132. Jablensky, A.; Sartorius, N.; Ernberg, G.; Anker, M.; Korten, A.; Cooper, J.E.; Day, R.; Bertelsen, A. (1991). Schizophrenia: Manifestations, Incidence, and Course in Different Cultures. A World Health Organization Ten-Country Study. Geneva: World Health Organization.
133. Jain, A.K.; Ryan, J.R.; McMahon, F.G.; Smith, G. (1981). Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol, 21:320S-326S.
134. Jones, R.T. (1980). Human effects: An overview. In: Peterson, R.C. (ed.), Marijuana Research Findings: 1980. NIDA Research Monograph 31 (pp. 54-80). Washington, DC: U.S. Government Printing Office.
135. Jones, R.T. (1984). Marijuana: Health and treatment issues. Psychiatr Clin North Am, 7:703-712.
136. Jones, R.T.; Benowitz, N. (1976). The 30-day trip—Clinical studies of cannabis tolerance and dependence. In: Braude, M.C.; Szara, S. (eds.), Pharmacology of Marihuana (pp. 627-642). New York: Raven Press.
137. Jones, R.T.; Stone, G.C. (1970). Psychological studies of marijuana and alcohol in man. Psychopharmacologia, 18:108-117.
138. Joy, J.E.; Watson, S.J.; Benson, J.A. (1999). Marijuana As Medicine: Assessing the Scientific Base. Washington, DC: National Academy Press.
139. Kalant, H. (1999). The Health Effects of Cannabis. Toronto: Centre for Addiction and Mental Health.
140. Kalant, H. (2004). Adverse effects of cannabis on health: An update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28:849-863.
141. Kamien, J.B.; Bickel, W.K.; Higgins, S.T.; Hughes, J.R. (1994). The effects of delta-9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-reports in humans. BehavPharmacol, 5:71-78.
142. Kandel, D.B. (1984). Marijuana users in young adulthood. Arch Gen Psychiatry, 41:200-209.
143. Kandel, D.B.; Davies, M. (1992). Progression to regular marijuana involvement: Phenomenology and risk factors of near daily use. In: Glantz, M.; Pickens, R. (eds.), Vulnerability to Drug Abuse (pp. 221-253). Washington, DC: American Psychological Association.
144. Kandel, D.B.; Davies, M.; Karus, D.; Yamaguchi, K. (1986). The consequences in young adulthood of adolescent drug involvement. Arch Gen Psychiatry, 43:746-754.
145. Kaymakcalan, S. (1973). Tolerance to and dependence on cannabis. Bull Narc, 25:39-47.
146. Kelly, T.H.; Foltin, R.W.; Emurian, C.S.; Fischman, M.W. (1990). Multidimensional behavioral effects of marijuana. Prog Neuropsychopharmacol Biol Psychiatry, 14:885-902.
147. Kelly, T.H.; Foltin, R.W.; Fischman, M.W. (1993). Effects of smoked marijuana on heart rate, drug ratings, and task performance by humans. Behav Pharmacol, 4:167-178.
148. Kelly, T.H.; Foltin, R.W.; Mayr, M.T.; Fischman, M.W. (1994). Effects of delta 9-tetrahydrocannabinol and social context on marijuana self-administration by humans. Pharmacol Biochem Behav, 49:763-768.
149. Klein, T.W. (1999). Cannabis and immunity. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 347-374). Toronto: Centre for Addiction and Mental Health.
150. Klein, T.W.; Friedman, H.; Specter, S. (1998). Marijuana, immunity, and infection. J Neuroimmunol, 83:102-115.
151. Klonoff, H. (1974). Marijuana and driving in real-life situations. Science, 186: 317-324.
152. Koob, G.F.; Caine, S.B.; Parsons, L.; Markou, A.; Weiss, F. (1997). Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav, 57:51-521.
153. Kouri, E.M.; Pope, H.G. (2000). Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol, 8:483-492.
154. Krohn, M.D.; Lizotte, A.J.; Perez, C.M. (1997). The interrelationship between substance use and precocious transitions to adult statuses. J Health Soc Behav, 38(1):87-103.
155. Kusher, D.I.; Dawson, L.O.; Taylor, A.C.; Djeu, J.Y. (1994). Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol, 154:99-108.
156. Leavitt, J.; Webb, P.; Norris, G.; Struve, F.; Straumanis, J.; Fitz-Gerald, M.; Nixon, F.; Patrick, G.; Manno, J. (1993). Performance of chronic daily marijuana users on neuropsychological tests. In: Harris, L. (ed.), Problems of Drug Dependence 1992 (p. 179). Washington, DC: U.S. Government Printing Office.
157. Leon, S.C.; Lyons, J.S.; Christopher, N.J.; Miller, S.I. (1998). Psychiatric hospital outcomes of dual diagnosis patients under managed care. Am J Addict, 7:81-86.
158. Levitt, M.; Faiman, C.; Hawks, R.; Wilson, A. (1984). Randomized double blind comparison of delta-9-tetrahydrocannabinol (THC) and marijuana as chemotherapy antiemetics. Proceedings of the Meeting of the American Society of Clinical Oncology, 3:91.
159. Lezak, M.D. (1995). Neurophysical Assessment, Third Edition. New York: Oxford University Press.
160. Libman, E.; Stern, M.H. (1985). The effects of delta-9-tetrahydrocannabinol on cutaneous sensitivity and its relation to personality. Pers Indiv Differ, 6:169-174.
161. Lichtman, A.H.; Wiley, J.L.; LaVecchia, K.L.; Niviaser, S.T.; Arthur, D.B.; Wilson, D.M.; Martin, B.R. (1998). Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. J Pharmacol Exp Ther, 278:1290-1295.
162. Liguori, A.; Gatto, C.P.; Jarrett, D.B. (2001). Effects of Marijuana-Alcohol Combinations on Mood, Equilibrium and Simulated Driving. Scottsdale, AZ: College on Problems of Drug Dependence.
163. Liguori, A.; Gatto, C.P.; Robinson, J.H. (1998). Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behav Pharmacol, 9:599-609.
164. Linszen, D.H.; Dingemans, P.M.; Lenior, M.E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry, 51:273-279.
165. Linszen, D.H.; Dingemans, P.M.; Nugter, M.A.; Does, A.; Scholte, W.F.; Lenior, M.A. (1997). Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophr Bull, 23:119-130.
166. Lynskey, M.; Hall, W. (2000). The effects of adolescent cannabis use on educational attainment: A review. Addiction, 95:1621-1630.
167. MacPhee, D. (1999). Effects of marijuana on cell nuclei: A review of the literature relating to the genotoxicity of cannabis. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 291-310). Toronto: Centre for Addiction and Mental Health.
168. Maddock, R.; Farrell, T.R.; Herning, R.; Jones, R.T. (1979). Marijuana and thermoregulation in a hot environment. In: Cox, B.; Lomax, P.; Milton, A.S.; Schonbaum, E. (eds.), Thermoregulatory Mechanisms and Their Therapeutic Implications (pp. 62-64). Basel, NY: Karger.
169. Malec, J.; Harvey, R.F.; Cayner, J. (1982). Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil, 63:116-118.
170. Mao, L.; Oh, Y. (1998). Does marijuana or crack cocaine cause cancer? [Comment] J Natl Cancer Inst, 90:1182-1183.
171. Marijuana Treatment Project Research Group. (2004). Brief Treatments for cannabis dependence: Findings from a randomized multisite trial. J Consul Clin Psychol, 72:455-466.
172. Marks, D.F.; MacAvoy, M.F. (1989). Divided attention performance in cannabis users and non-users following alcohol and cannabis separately and in combination. Psychopharmacology (Berl), 99:397-401.
173. Marks, W.H.; Florence, L.; Lieberman, J.; Chapman, P.; Howard, D.; Roberts, P.; Perkinson, D. (1996). Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation, 61:1771-1774.
174. Marques-Magallanes, J.A.; Tashkin, D.P.; Serafian, T.; Stegeman, J.; Roth, M.D. (1997). In vivo and in vitro activation of cytochrome P4501A1 by marijuana smoke. 1997Symposium on the Cannabinoids of the International Cannabinoid Research Society, Stone Mountain, GA.
175. Martinez-Arevalo, M.J.; Calcedo-Ordonez, A.; Varo-Prieto, J.R. (1994). Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry, 164:679-681.
176. Mathers, D.C.; Ghodse, A.H.; Caan, A.W.; Scott, S.A. (1991). Cannabis use in a large sample of acute psychiatric admissions. Br J Addict, 86:779-784.
177. Mayor’s Committee on Marijuana (1944). The Marijuana Problem in the City of New York. Lancaster, PA: Jacques Cattell Press.
178. McGee, R.; Williams, S.; Poulton, R.; Moffitt, T. (2000). A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction, 95:491-503.
179. McGlothlin, W.H.; West, L.J. (1968). The marijuana problem: An overview. Am J Psychiatry, 125:370-378.
180. Meinck, H.M.; Schonle, P.W.; Conrad, B. (1989). Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol, 236:120-122.
181. Mendelson, J.H.; Mello, N.K.; Cristofaro, P.; Ellingboe, J.; Benedikt, R. (1985). Acute effects of marijuana on pituitary and gonadal hormones during the perio-vulatory phase of the menstrual cycle. In: Harris, L.S. (ed.), Problems of Drug Dependence (pp. 24-31). Washington, DC: U.S. Government Printing Office.
182. Mendelson, J.H.; Mello, N.K.; Ellingboe, J.; Skupny, A.T.; Lex, B.W.; Griffin, M. (1986). Marijuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther, 237:862-866.
183. Mendelson, J.H.; Mello, N.K.; Lex, B.W.; Bavli, S. (1984). Marijuana withdrawal syndrome in a woman. Am J Psychiatry, 141:1289-1290.
184. Mendelson, J.H.; Rossi, A.M.; Meyer, R.E. (1974). The Use of Marijuana: A Psychological and Physiological Inquiry. New York: Plenum Press.
185. Miles, C.G.; Congreve, G.R.S.; Gibbins, R.J.; Marshman, J.; Devenyi, P.; Hicks, R.C. (1974). An experimental study of the effects of daily cannabis smoking on behaviour patterns. Acta Pharmacol Toxicol, 34(1):1-43.
186. Miller-Johnson, S.; Lochman, J.E.; Cone, J.D.; Terry, R.; Hyman, C. (1998). Comorbidity of conduct and depressive problems at sixth grade: Substance use outcomes across adolescence. J Abnorm Child Psychol, 26:221-232.
187. Millsaps, C.L.; Azrin, R.L.; Mittenberg, W. (1994). Neuropsychological effects of chronic cannabis use on the memory and intelligence of adolescents. J Child Adolesc Sub Abuse, 3:47-55.
188. Moore, B.A.; Augustson, E.M.; Moser, R.P.; Budney, A.J. (2005). Respiratory effects of marijuana and tobacco use in a U.S. Sample. J Gen Intern Med, 20(1):33-37.
189. Moore, B.A.; Budney, A.J. (2001). Tobacco smoking in marijuana dependent outpatients. J Subst Abuse, 13:585-598.
190. Moore, B.A.; Budney, A.J. (2003). Relapse in outpatient treatment for marijuana dependence. J Substance Abuse Treat, 25(2):85-89.
191. Mouzak, A.; Agathos, P.; Kerezoudi, E.; Mantas, A.; Vourdeli-Yiannakoura, E. (2000). Transient ischemic attack in heavy cannabis smokers—How “safe” is it? EurNeurol, 44:42-44.
192. Mueser, K.T.; Yarnold, P.R.; Levinson, D.F.; Singh, H.; Bellack, A.S.; Kec, K.; Morrison, R.L.; Yadalam, K. G. (1990). Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull, 16:31-56.
193. Murphy, L. (1999). Cannabis effects on endocrine and reproductive function. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), Health Effects of Cannabis (pp. 375-400). Toronto: Centre for Addiction and Mental Health.
194. Negrete, J.C. (1989). Cannabis and schizophrenia. Br J Addict, 84:349-351.
195. Negrete, J.C.; Gill, K. (1999). Cannabis and schizophrenia: An overview of the evidence to date. In: Nahas, G.G. (ed.), Marijuana and Medicine (pp. 671-681). Totowa, NJ: Humana Press.
196. Newton, C.A.; Klein, T.W.; Friedman, H. (1994). Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun, 62:4015-4020.
197. Nowlan, R.; Cohen, S. (1977). Tolerance to marijuana: Heart rate and subjective “high.” Clin Pharmacol Ther, 22:550-556.
198. Noyes, R. Jr.; Brunk, S.F.; Avery, D.H.; Canter, A. (1975). The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther, 18:84-89.
199. Noyes, R. Jr.; Brunk, S.F.; Baram, D.; Canter, A. (1975). Analgesic effect of delta 9-tetrahydrocannabinol. J Clin Pharmacol, 15:139-143.
200. O’Connell, C.M.; Fried, P.A. (1984). An investigation of prenatal cannabis exposure and minor physical anomalies in a low risk population. Neurotoxicol Teratol, 6:345-350.
201. O’Connell, C.M.; Fried, P.A. (1991). Prenatal exposure to cannabis: A preliminary report of postnatal consequences in school-age children. Neurotoxicol Teratol, 13:631-639.
202. Patton, G.C.; Coffey, C.; Carlin, J.B.; Degenhardt, L.; Lynskey, M.; Hall, W. (2002). Cannabis use and mental health in young people: Cohort study. Br Med J 325:1195-1198.
203. Peck, R.C.; Biasotti, A.; Boland, P.N.; Mallory, C.; Reeve, V. (1986). The effects of marijuana and alcohol on actual driving performance. Alcohol, Drugs and Driving, 2:135-154.
204. Perez-Reyes, M.; Hicks, R.E.; Bumberry, J.; Jeffcoat, A.R.; Cook, C.E. (1988). Interaction between marijuana and ethanol: Effects on psychomotor performance. Alcohol Clin Exp Res, 12:268-276.
205. Perez-Reyes, M.; Lipton, M.A.; Timmons, M.C.; Walls, M.E.; Brine, D.R.; Davis, K.H. (1973). Pharmacology of administered delta-9-tetrahydrocannabinol. Clin Pharmacol Ther, 14:48-55.
206. Perez-Reyes, M.; White, W.R.; McDonald, S.A.; Hicks, R.E.; Jeffcoat, A.R.; Cook, C.E. (1991). The pharmocologic effects of daily marijuana smoking in humans. Pharmacol Biochem Behav, 40:691-694.
207. Petro, D.J.; Ellenberger, C. Jr. (1981). Treatment of human spasticity with delta 9-tetrahydrocannabinol. J Clin Pharmacol, 21:413S-416S.
208. Pickworth, W.B.; Rohrer, M.S.; Fant, R.V. (1997). Effects of abused drugs on psychomotor performance. Exp Clin Psychopharmachol, 5:235-241.
209. Pihl, R.O.; Sigal, H. (1978). Motivational levels and the marijuana high. J Abnorm Psychol, 87(2):280-285.
210. Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane, M.; Shepard, K.V.; Wadleigh, R.G. (1991). Recent clinical experience with dronabinol. Pharmacol Biochem Behav, 40:695-700.
211. Polen, M.R.; Sidney, S.; Tekawa, I.S.; Sadler, M.; Friedman, G.D. (1993). Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med, 158:596-601.
212. Pope, H.G. Jr.; Gruber, A.J.; Hudson, J.I.; Huestis, M.A.; Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry, 58:909-915.
213. Pope, H.G.; Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. JAMA, 275:521-527.
214. Rachlinski, J.J.; Foltin, R.W.; Fischman, M.W. (1989). The effects of smoked marijuana on interpersonal distances in small groups. Drug Alcohol Depend, 24:183-186.
215. Raft, D.; Gregg, J.; Ghia, J.; Harris, L. (1977). Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: Psychological correlates of the analgesic response. Clin Pharmacol Ther, 21:26-33.
216. Rainone, G.A.; Deren, S.; Kleinman, P.H.; Wish, E.D. (1987). Heavy marijuana users not in treatment: The continuing search for the “pure” marijuana user. J Psychoactive Drugs, 19:353-359.
217. Ramaekers, J.G.; Berghaus, G.; van Laar, M.; Drummer, O.H. (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend, 73:109-119.
218. Ramaekers, J.G.; Robbe, H.W.J.; O’Hanlon, J.F. (2000). Marijuana, alcohol, and actual driving performance. Human Psychopharmacol, 15:551-558.
219. Renaud, A.M.; Cormier, Y. (1986). Acute effects of marijuana smoking on maximal exercise performance. Med Sci Sports Exerc, 18:685-689.
220. Richardson, G.A.; Ryan, C.; Willford, J.; Day, N.L.; Goldschmidt, L. (2002). Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol, 24:309-320.
221. Richardson, M.S.; Craig, T.J.; Haugland, G. (1985). Treatment patterns of young chronic schizophrenic patients in the era of deinstitutionalization. Psychiatr Q, 57:104-110.
222. Robbe, H.J.; O’Hanlon, J.F. (1999). Marijuana and Actual Driving Performance. Washington, DC: National Highway Transportation Administration.
223. Roffman, R.K.; Barnhart, R. (1987). Assessing need for marijuana dependence treatment through an anonymous telephone interview. Int J Addict, 22:639-651.
224. Roth, M.D.; Arora, A.; Barsky, S.H.; Kleerup, E.C.; Simmons, M.; Tashkin, D.P. (1998). Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med, 157:928-937.
225. Roth, M.D.; Baldwin, G.C.; Tashkin, D.P. (2002). Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids, 121(1-2):229-239.
226. Roth, M.D.; Whittaker, K.; Salehi, K.; Tashkin, D.P.; Baldwin, G.C. (2004). Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. JNeuroimmunol, 147(1-2):82-86.
227. Rubin, F.; Comitas, L. (1976). Ganja in Jamaica. Garden City, NY: Doubleday.
228. Sallan, S.E.; Zinberg, N.E.; Freii, E. (1975). Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med, 293:795-797.
229. Sallan, S.E.; Cronin, C.; Zelen, M.; Zinberg, N.E. (1980). Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med, 302:135-138.
230. Sasco, A.J.; Merrill, R.M.; Dari, I.; Benhaim-Luzon, V.; Carriot, F.; Cann, C.I.; Bartal, M. (2002). A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control, 13(7):609-616.
231. Schuckit, M.A. (1990). Drug Abuse and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. New York: Plenum Medical Book Company.
232. Schwartz, R.H. (1987). Marijuana: An overview. Pediatr Clin North Am, 34(2): 305-317.
233. Schwartz, R.H.; Beveridge, R.A. (1994). Marijuana as an antiemetic drug: How useful is it today? Opinions from clinical oncologists. JAddict Dis, 13:53-65.
234. Schwartz, R.H.; Gruenewald, PJ.; Klitzner, M.; Fedio, P. (1989). Short-term memory impairment in cannabis-dependent adolescents. Am J Dis Child, 143:1214-1219.
235. Shapiro, B.J.; Reiss, S.; Sullivan, S.F.; Tashkin, D.P.; Simmons, M.S.; Smith, R.T. (1976). Cardiopulmonary effects of marijuana smoking during exercise. Chest, 70:1351-1356.
236. Shay, A.H.; Choi, R.; Whittaker, K.; Salehi, K.; Kitchen, C.M.R.; Tashkin, D.P.; Roth, M.D.; Baldwin, G.C. (2003). Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J Infect Dis, 187(4):700-704.
237. Sherman, M.P.; Aeberhard, E.E.; Wong, V.Z.; Simmons, M.S.; Roth, M.D.; Tashkin, D.P. (1995). Effects of smoking marijuana, tobacco, or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci, 56: 2201-2207.
238. Sherman, M.P.; Campbell, L.A.; Gong, H.J.; Roth, M.D.; Tashkin, D.P. (1991). Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am Rev Respir Dis, 144: 1351-1356.
239. Sidney, S.; Quesenberry, C.P.; Friedman, G.D.; Tekawa, I.S. (1997). Marijuana use and cancer incidence (California, United States). Cancer Causes Control, 8:722-728.
240. Smiley, A.M.; Moskowitz, H.; Zeidman, K. (1981). Driving simulator studies of marijuana alone and in combination with alcohol. Proceedings of the 25th Conference of the American Association for Automotive Medicine (pp. 107-116), Amsterdam.
241. Smiley, A.M.; Noy, Y.I.; Tostowaryk, W. (1986). The effects of marijuana, alone and in combination with alcohol, on driving an instrumented car. Proceedings of the 10th International Conference on Alcohol, Drugs, and Traffic Safety (pp. 203-206), Amsterdam.
242. Solowij, N. (1999). Long-term effects of cannabis on the central nervous system. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 195-266). Toronto: Centre for Addictions and Mental Health.
243. Solowij, N.; Grenyer, B.F.S.; Chesher, G.; Lewis, J. (1995). Biopsychosocial changes associated with cessation of cannabis use: A single case study of acute and chronic cognitive effects, withdrawal, and treatment. Life Sci, 56:2127-2134.
244. Solowij, N.; Grenyer, B.F.S.; Peters, R.; Chesher, G. (1997). Long term cannabis use impairs memory processes and frontal lobe function. 1997 Symposium on the Cannabinoids (p. 84). Burlington, VT: International Cannabinoid Research Society.
245. Solowij, N.; Stephens, R.S.; Roffman, R.A.; Kadden, T.; Miller, R.; Christiansen, M.; McRee, K.; Vendetti, B. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Assoc, 287:1123-1131.
246. Soni, S.D.; Brownlee, M. (1991). Alcohol abuse in chronic schizophrenics: Implications for management in the community. Acta Psychiatr Scand, 84: 272-276.
247. Sridhar, K.S.; Raub, W.A.; Weatherby, N.L.; Metsch, L.R. (1995). Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs, 26:285-288.
248. Staquet, M.; Gantt, C.; Machin, D. (1978). Effect of nitrogen analog of tetra hydrocannabinol of cancer pain. Clin Pharmacol Ther, 23:397-401.
249. Stefanis, C.; Dornbush, R.; Fink, M. (1977). Hashish: Studies of Long-Term Use. New York: Raven Press.
250. Stein, A.C.; Allen, R.W.; Cook, M.L.; Karl, R.L. (1983). A Simulator Study of the Combined Effects of Alcohol and Marijuana on Driving Behaviour. Hawthorne, CA: National Highway Traffic Safety Administration.
251. Stephens, R.S. (1999). Cannabis and hallucinogens. In: McCrady, B.S.; Epstein, E.E. (eds.), Addictions (pp. 121-140). New York: Oxford University Press.
252. Stephens, R.S.; Roffman, R.A.; Curtin, L. (2000). Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol, 68:898-908.
253. Stephens, R.S.; Roffman, R.A.; Simpson, E.E. (1993). Adult marijuana users seeking treatment. J Consult Clin Psychol, 61(6):1100-1104.
254. Stephens, R.S.; Roffman, R.A.; Simpson, E.E. (1994). Treating adult marijuana dependence: A test of the relapse prevention model. J Consult Clin Psychol, 62:92-99.
255. Substance Abuse and Mental Health Services Administration (SAMHSA) (2005a). Summary of Findings from the 1998National Household Survey on Drug Abuse. Rockville, MD: U.S. Department of Health and Human Services.
256. Substance Abuse and Mental Health Services Administration (SAMHSA) (2005b). National Admissions to Substance Abuse Treatment Services—The Treatment Episode Data Set (TEDS). http://www.icpsr.umich.edu/cocoon/SAMHDA/SERlES/00056.xml.
257. Tahir, S.K.; Zimmerman, A.M. (1991). Influence of marijuana on cellular structures and biochemical activities. Pharmacol Biochem Behav, 40:617-623.
258. Tanner, J.; Davies, S.; O’Grady, B. (1999). Whatever happened to yesterday’s rebels? Longitudinal effects of youth delinquency on education and employment. Soc Probl, 46:250-274.
259. Tashkin, D.P. (1999). Cannabis effects on the respiratory system. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), The Health Effects of Cannabis (pp. 311-346). Toronto: Centre for Addiction and Mental Health.
260. Tashkin, D.P.; Coulson, A.H.; Clark, V.A.; Simmons, M.; Borque, L.B.; Duann, S.; Spivey, G.H.; Gong, H. (1987). Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis, 135:209-216.
261. Tashkin, D.P.; Gliederer, F.; Rose, J.; Change, P.; Hui, K.K.; Yu, J.L.; Wu, T.C. (1991). Effects of varying marijuana smoking profile on disposition of tar and absorption of CO and delta-9-THC. Pharmacol Biochem Behav, 40: 651-656.
262. Tashkin, D.P.; Shapiro, B.J.; Frank, I.M. (1973). Acute pulmonary physiologic effects of smoked marijuana and oral delta-9-tetrahydrocannabinol in healthy young men. N Engl J Med, 289(7):336-341.
263. Tashkin, D.P.; Shapiro, B.J.; Lee, Y.E.; Harper, C.E. (1975). Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis, 112:377-386.
264. Taylor, D.R.; Fergusson, D.M.; Milne, B.J.; Horwood, L.J.; Moffitt, T.E.; Sears, M.R.; Poulton, R. (2002). A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction, 97(8): 1055-1061.
265. Taylor, D.R.; Poulton, R.; Moffitt, T.E.; Ramankutty, P.; Sears, M.R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 95:1669-1677.
266. Taylor, F.M. (1988). Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population. South Med J, 81:1213-1216.
267. Tennes, K.; Avitable, N.; Blackard, C.; Boyles, C.; Hassoun, B.; Holmes, L.; Kreye, M. (1985). Marijuana: Prenatal and postnatal exposure in the human. In: Pinkert, T.M. (ed.), Current Research on the Consequences of Maternal Drug Abuse (pp. 48-60). Washington, DC: U.S. Government Printing Office.
268. Thacore, V.R.; Shukla, S.P. (1976). Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry, 33:383-386.
269. Thomas, H. (1996). A community survey of adverse effects of cannabis use. Drug Alcohol Depend, 42:201-207.
270. Thornicroft, G. (1990). Cannabis and psychosis: Is there epidemiological evidence for association? Br J Psychiatry 157:25-33.
271. Tilles, D.S.; Goldenheim, P.D.; Johnson, D.C.; Mendelson, J.A.; Mellow, N.K.; Hales, C.A. (1986). Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity. Am J Med, 80:601-606.
272. Timpone, J.G.; Wright, D.J.; Egorin, M.J.; Enama, M.E.; Mayers, J.; Galetto, G. (1997). The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. AIDS Res Hum Retroviruses, 13:305-315.
273. Ungerleider, J.T.; Andrysiak, Y.; Fairbanks, L.; Ellison, G.W.; Myers, L.W. (1987). Delta-9-THC in the treatment for spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse, 7:39-50.
274. Vachon, L.; Fitzgerald, M.X.; Solliday, N.F.; Gould, I.A.; Gaensler, E.A. (1973). Single-dose effect of marijuana smoke: Bronchial dynamics and respiratory center sensitivity in normal subjects. N Engl J Med, 288:985-989.
275. Vandrey, R.G.; Budney, A.J.; Hughes, J.R.; Liguori, A. (in press). A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug and Alcohol Dependence.
276. Vandrey, R.G.; Budney, A.J.; Kamon, J.; Stanger, C. (2005). Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend, 78:205-210.
277. Vandrey, R.; Budney, A.J.; Moore, B.A.; Hughes, J.R. (2005). Comparison of tobacco and marijuana withdrawal. Am J Addict, 14:54-63.
278. VanHoozen, B.E.; Cross, C.E. (1997). Marijuana: Respiratory tract effects. Clin Rev Allergy Immunol, 15:243-269.
279. van Os, J.; Bak, M.; Hanssen, M.; Bijl, R.; de Graaf, R.; Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol, 156:319-327.
280. Verweij, P.E.; Kerremans, J.J.; Voss, A.; Meis, J.F. (2000). Fungal contamination of tobacco and marijuana. JAMA, 384:2875.
281. Wallace, J.M.; Oishi, J.S.; Barbers, R.G.; Simmons, M.S.; Tashkin, D.P. (1994). Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers. Chest, 105:847-852.
282. Walton, R.P. (1938). Marijuana—America’s New Drug Problem. Philadelphia: J.P. Lippincott.
283. Wells, J.E.; Bushnell, J.A.; Joyce, P.R.; Oakley-Browne, M.A.; Hornblow, A.R. (1992). Problems with alcohol, drugs and gambling in Christchurch, New Zealand. In: Abbot, M.; Evans, K. (eds.), Alcohol and Drug Dependence and Disorders of Impulse Control (pp. 3-13). Auckland, New Zealand: Alcohol Liquor Advisory Council.
284. Wert, R.C.; Raulin, M.L. (1986a). The chronic cerebral effects of cannabis use: I. Methodological issues and neurological findings. Int J Addict, 21:605-628.
285. Wert, R.C.; Raulin, M.L. (1986b). The chronic cerebral effects of cannabis use: II. Psychological findings and conclusions. Int J Addict, 21:629-642.
286. Wetzel, C.D.; Janowsky, D.S.; Clopton, P.L. (1982). Remote memory during marijuana intoxication. Psychopharmacology (Berl), 76:278-281.
287. Witter, F.R.; Niebyl, J.R. (1990). Marijuana use in pregnancy and pregnancy outcome. Am JPerinatol, 7:36-38.
288. World Health Organization (WHO) (1992). Classification of mental and behavioural disorders: Clinical description and diagnostic guidelines. In: International Statistical Classification of Diseases and Related Health Programs, Tenth Revision. Geneva: WHO.
289. Wu, T.C.; Tashkin, D.P.; Djahed, B.; Rose, J.E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med, 318:347-351.
290. Zacny, J.P.; Chait, L.D. (1989). Breathhold duration and response to marijuana smoke. Pharmacol Biochem Behav, 33:481-484.
291. Zammit, S.; Allebeck, P.; Andreasson, S.; Lundberg, I.; Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. Br Med J, 325:1199-1201.
292. Zhang, Z.F.; Morgenstern, H.; Spitz, M.R.; Tashkin, D.P.; Yu, G.P.; Marshall, J.R.; Hsu, T.C. (1999). Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev, 8:1071-1078.
293. Zhu, L.X.; Sharma, S.; Stolina, M.; Gardner, B.; Roth, M.D.; Tashkin, D.P.; Dubinett, S.M. (2000). Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol, 165:373-380.
294. Zuckerman, B.; Frank, D.; Hingson, R.; Amaro, H.; Levenson, S.; Kayne, H.; Parker, S. et al. (1989). Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med, 320:762-768.